NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19

(University of California - San Diego) The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites and is led by Davey Smith, MD, of UC San Diego School of Medicine.